Literature DB >> 3463558

Pefloxacin concentrations in human aqueous humour and lens.

A Salvanet, A Fisch, C Lafaix, G Montay, P Dubayle, F Forestier, G Haroche.   

Abstract

In 20 patients undergoing cataract extraction, we measured pefloxacin concentrations in the eye. After a 1 h infusion of pefloxacin 400 mg iv, the mean pefloxacin concentrations 2, 6, 12 and 24 h post-infusion were 0.75, 1.45, 1.04 and 0.86 mg/l, respectively. The simultaneous mean pefloxacin concentrations in the lens were 0.09, 0.20, 0.26 and 0.43 mg/l, respectively. The adequate penetration of pefloxacin into uninfected aqueous humour and lens suggests that this antibiotic may be effective in the treatment of certain bacterial endophthalmic infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3463558     DOI: 10.1093/jac/18.2.199

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

Review 1.  Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.

Authors:  J H Paton; D S Reeves
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

Review 2.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

3.  Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.

Authors:  I Cochereau-Massin; J Bauchet; F Faurisson; J M Vallois; P Lacombe; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

4.  Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.

Authors:  I Cochereau-Massin; J Bauchet; S Marrakchi-Benjaafar; A Saleh-Mghir; F Faurisson; J M Vallois; E Vallee; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 5.  Use of quinolones for treatment of ear and eye infections.

Authors:  M Barza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

6.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

Review 7.  Pefloxacin clinical pharmacokinetics.

Authors:  F Bressolle; F Gonçalves; A Gouby; M Galtier
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

8.  Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.

Authors:  H Giamarellou; D Kanellas; E Kavouklis; G Petrikkos; L Gabriel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

9.  Tolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.

Authors:  S Marrakchi-Benjaafar; I Cochereau; F D'Hermies; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.